PRESS RELEASE published on 10/23/2024 at 18:45, 1 year 6 months ago 2023-2024 annual results : Solid growth in revenue and recurring operating margin of 8.5%, exceeding the target / improved profitability and a focus on reducing debt in 2024-25 Groupe Bastide announces 2023-2024 financial year earnings, with revenue of €529.8 million and organic growth of 7.4%. Recurring operating margin exceeds target. Debt reduction and leverage improvement are key goals for the future Revenue Financial Year Earnings Debt Reduction Groupe Bastide
PRESS RELEASE published on 10/23/2024 at 18:30, 1 year 6 months ago Résultats annuels 2023-2024 : Croissance solide du chiffre d'affaires, marge opérationnelle courante de 8,5%, supérieure à l'objectif / Amélioration de la profitabilité et priorité au désendettement en 2024-25 Le Groupe Bastide annonce ses résultats annuels 2023-2024 avec une croissance organique de +7,4% et une marge opérationnelle courante de 8,5%. Perspectives positives pour 2024-2025 Marge Opérationnelle Résultats Annuels Croissance Organique Groupe Bastide Perspectives 2024-2025
PRESS RELEASE published on 10/23/2024 at 18:30, 1 year 6 months ago Information financière trimestrielle / Information financière du troisième trimestre
PRESS RELEASE published on 10/23/2024 at 18:30, 1 year 6 months ago Quarterly financial reporting / Third quarter financial report Clariane reports 6.3% organic revenue growth for the first nine months of 2024, confirming 2024 guidance of over 5% growth. Progress on €1bn disposal plan Revenue Growth Organic Growth 2024 Guidance Clariane Disposal Plan
PRESS RELEASE published on 10/23/2024 at 18:21, 1 year 6 months ago SYNERGIE : CHIFFRE D’AFFAIRES 3ème TRIMESTRE 2024 SYNERGIE affiche une croissance de +2,1% de son chiffre d'affaires au T3 2024 malgré un contexte économique difficile, avec une part croissante de l'international Chiffre D'affaires Croissance International SYNERGIE T3 2024
PRESS RELEASE published on 10/23/2024 at 18:21, 1 year 6 months ago SYNERGIE : Q3 2024 REVENUES SYNERGIE Group reports €810.5 million revenues in Q3 2024, up +2.1%, with international business driving growth and French market facing challenges Revenues French Market Q3 2024 International Business SYNERGIE Group
PRESS RELEASE published on 10/23/2024 at 18:10, 1 year 6 months ago Amadeus Fire AG: Slight increase in revenue and operating gross profit of the Amadeus Fire Group after nine months in 2024 Amadeus Fire Group reports slight revenue increase and operating gross profit in Q3 2024 despite economic challenges in Germany Revenue Increase Gross Profit Q3 2024 Economic Challenges Amadeus Fire Group
PRESS RELEASE published on 10/23/2024 at 18:08, 1 year 6 months ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Holdings plc purchased 109,815 Ordinary Shares for cancellation, with highest price at 147.00p and lowest at 140.50p. Share capital post-cancellation: 333,406,899 shares London Stock Exchange Ordinary Shares Market Abuse Regulation Share Buyback Programme Funding Circle Holdings PLC
PRESS RELEASE published on 10/23/2024 at 18:05, 1 year 6 months ago Alan Allman Associates conserve une croissance de chiffre d'affaires sur 9 mois de +4% Alan Allman Associates maintient une croissance de +4% de son chiffre d'affaires sur les 9 premiers mois de 2024, avec une stabilité au 3ème trimestre. Focus sur les zones de croissance: Péninsule Ibérique et APAC Chiffre D'affaires Croissance APAC Alan Allman Associates Péninsule Ibérique
PRESS RELEASE published on 10/23/2024 at 18:00, 1 year 6 months ago BIOSYNEX SA: CHEMBIO DIAGNOSTICS INC, FILIALE DE BIOSYNEX, REÇOIT UNE SUBVENTION POUR LE DEVELOPPEMENT D'UN TEST DPP POUR LA SYPHILIS CONGENITALE BIOSYNEX SA: Chembio Diagnostics Inc, filiale de BIOSYNEX, reçoit une subvention pour le développement d'un test DPP pour la syphilis congénitale. La Bill & Melinda Gates Foundation finance un test rapide au chevet du patient Subvention BIOSYNEX SA Syphilis Congénitale Chembio Diagnostics Inc Test DPP
Published on 05/16/2026 at 01:15, 12 minutes ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 1 hour 27 minutes ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 2 hours 17 minutes ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/15/2026 at 23:00, 2 hours 27 minutes ago Jericho Energy Ventures Announces Transition to Semi-Annual Reporting to Enhance Efficiency
Published on 05/15/2026 at 20:10, 5 hours 17 minutes ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 7 hours 17 minutes ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 17:33, 7 hours 53 minutes ago Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Published on 05/15/2026 at 15:08, 10 hours 19 minutes ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 10 hours 27 minutes ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 15 hours 17 minutes ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 1 day 16 hours ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 2 days 7 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES